ATLANTA--(EON: Enhanced Online News)--In conjunction with Breast Cancer Awareness month, Munich American Reassurance Company announced key enhancements to its EDGE Life and Disability Income (DI) underwriting manuals, including a groundbreaking breast cancer rating grid and inclusion of breast cancers into its tumor calculator.
“Breast cancer is the most common form of cancer amongst women, and, recently, medical science has made large strides in early detection and effective treatment”
“Breast cancer is the most common form of cancer amongst women, and, recently, medical science has made large strides in early detection and effective treatment,” says Bill Moore, Vice President, Underwriting and Medical Services, Munich American Reassurance Company. “We thought it was a great opportunity for our underwriting guidelines to reflect the progress that’s been made in diagnosing and treating breast cancer.”
Using evidenced-based research, including SEER (Surveillance, Epidemiology and End Results) data, EDGE takes a unique approach that can, in many cases, lead to more competitive offers much sooner after treatment, many at standard rates.
“By expanding our recently-released tumor calculator to include breast cancer, we have taken advantage of the advancements made in detection and treatment,” says Marylou Dunn, Assistant Vice President and Chief Underwriter for Munich Re Canada (Life). “With research demonstrating that more breast cancer survivors are insurable, EDGE can support more offers at standard rates, or utilize table ratings versus the temporary extra method when standard is not possible.”
The EDGE DI underwriting manual includes new/updated content and rating grids on osteoporosis, osteopenia, ankle fractures, ankle sprains/strains and ankle tendonopathies.
More information about the EDGE underwriting manuals can be found by going to www.marclife.com and clicking on Underwriting Manuals.
Munich American Reassurance Company, founded in 1959, is one of the largest reinsurers in the U.S. offering life and disability reinsurance to insurance companies throughout the United States. The company also writes group, credit and other reinsurance products. Headquartered in Atlanta, with an office in Chicago, Munich American is licensed, accredited or authorized in all fifty states; Washington, D.C.; Guam; and Puerto Rico.
Munich Re stands for exceptional solution-based expertise, consistent risk management, financial stability and client proximity. This is how Munich Re creates value for clients, shareholders and staff. In the financial year 2012, the Group – which combines primary insurance and reinsurance under one roof – achieved a profit of €3.2bn on premium income of around €52bn. It operates in all lines of insurance, with around 45,000 employees throughout the world. With premium income of around €28bn from reinsurance alone, it is one of the world’s leading reinsurers. Especially when clients require solutions for complex risks, Munich Re is a much sought-after risk carrier. Its primary insurance operations are concentrated mainly in the ERGO Insurance Group, one of the major insurance groups in Germany and Europe. ERGO is represented in over 30 countries worldwide and offers a comprehensive range of insurances, provision products and services. In 2012, ERGO posted premium income of €19bn. In international healthcare business, Munich Re pools its insurance and reinsurance operations, as well as related services, under the Munich Health brand. Munich Re’s global investments amounting to €214bn are managed by MEAG, which also makes its competence available to private and institutional investors outside the Group.
This press release contains forward-looking statements that are based on current assumptions and forecasts of the management of Munich Re. Known and unknown risks, uncertainties and other factors could lead to material differences between the forward-looking statements given here and the actual development, in particular the results, financial situation and performance of our Company. The Company assumes no liability to update these forward-looking statements or to conform them to future events or developments.